Lakewood-Amedex Biotherapeutics Inc. (LABT)
NASDAQ · Manufacturing · Pharmaceutical preparations
LABT price, last 12 months
Key stats
- Previous close
- $1.83
- Open
- $1.84
- Day range
- $1.60 – $1.97
- 52-week range
- $1.60 – $98.20
- Volume
- 169.9K
- Avg volume (20 days)
- 1.3M
- Market cap
- $4.0M
Performance
Technicals and fundamentals
About Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $4.0M